Selective Estrogen Receptor Modulators (SERMs): Advances, Challenges, and Future Prospects in ER+ Breast Cancer Therapy
Year: 2026
Type: article
Source: Archiv der Pharmazie
DOI: 10.1002/ardp.70206
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7129495598
